Showing results (21-30 of 170) with videos related to
Sort By:
Pageof 17
Journal for Immunotherapy of Cancer|July 14, 2019
Response to combined ipilimumab and nivolumab after development of a nephrotic syndrome related to PD-1 monotherapyValerie Glutsch, Franziska Grän, Judith Weber, et al.Journal of Molecular Medicine (Berlin, Germany)|September 15, 2011
IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment modelBastian Schilling, Malgorzata Harasymczuk, Patrick Schuler, et al.Journal of Immunological Methods|April 24, 2012
Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samplesAthanasios Kotsakis, Malgorzata Harasymczuk, Bastian Schilling, et al.Seminars in Oncology|November 16, 2010
Update on immunologic therapy with anti-CTLA-4 antibodies in melanoma: identification of clinical and biological response patterns, immune-related adverse events, and their managementKatharina C Kaehler, Sarah Piel, Elisabeth Livingstone, et al.Plos One|February 15, 2013
IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cellsBastian Schilling, Malgorzata Harasymczuk, Patrick Schuler, et al.Pediatric Research|July 17, 2013
Reduced frequency of CD56 dim CD16 pos natural killer cells in pediatric systemic inflammatory response syndrome/sepsis patientsE Scott Halstead, Joseph A Carcillo, Bastian Schilling, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 13, 2025
Brentuximab vedotin as monotherapy or combination therapy for cutaneous peripheral T cell lymphoma - a retrospective studyCaroline Glatzel, Inga Hansen-Abeck, Nina Booken, et al.Acta Dermato-Venereologica|May 26, 2020
Indirect Comparison of Combined BRAF and MEK Inhibition in Melanoma Patients with Elevated Baseline Lactate DehydrogenaseValerie Glutsch, Teresa Amaral, Claus Garbe, et al.Analytical Chemistry|October 4, 2022
Extending the Mass Spectrometry-Detectable Landscape of MHC Peptides by Use of Restricted Access MaterialMelissa Bernhardt, Yiliam Cruz-Garcia, Anne Rech, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2018
Patterns of disease control and survival in patients with melanoma brain metastases undergoing immune-checkpoint blockadeLaura Milsch, Anja Gesierich, Sophia Kreft, et al.Pageof 17